Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trialAlexander M.M. Eggermont, Ulrich Keilholz, Wim H.J. Kruit et al.|The Lancet|2008Cited by 642
Long-Term Results of the Randomized Phase III Trial EORTC 18991 of Adjuvant Therapy With Pegylated Interferon Alfa-2b Versus Observation in Resected Stage III MelanomaAlexander M.M. Eggermont, Ulrich Keilholz, Stefan Suciu et al.|Journal of Clinical Oncology|2012Cited by 281